drugset / Trial / NCT01125813

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

NCT01125813

Phase 3 Completed 32 enrolled Octapharma
NaSingle-groupOpen-labelPrevention

Summary

This study will determine the efficacy of human-cl rhFVIII in previously treated patients with severe hemophilia A during prophylactic treatment, treatment of bleeding episodes and in surgical prophylaxis.

Timeline

Start
2010-06
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ADVATE Protein / enzyme biologic Intravenous

Indications